Cargando…
Recurrent Erythema Multiforme Induced by the Combination of Pembrolizumab and Radiation
Erythema multiforme is a self-limited condition that is characterized by the rapid onset of symmetric targetoid lesions. This hypersensitivity reaction is commonly triggered by herpes simplex virus and Mycoplasma pneumoniae infections. Pembrolizumab is an anti-programmed cell death protein 1 (PD-1)...
Autores principales: | Ambur, Austin B, Mammino, Jason, Nathoo, Rajiv |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8642132/ https://www.ncbi.nlm.nih.gov/pubmed/34877195 http://dx.doi.org/10.7759/cureus.19202 |
Ejemplares similares
-
Recurrent Drug-Induced Hypersensitivity Syndrome Following Bortezomib for Multiple Myeloma
por: Ambur, Austin B, et al.
Publicado: (2021) -
A Case of Drug-Induced Bullous Pemphigoid With an Isomorphic Response and Updated Review of Koebnerization in Bullous Diseases
por: Ambur, Austin B, et al.
Publicado: (2021) -
Recurrent Erythema Multiforme Major Following COVID-19 Infection
por: Rykiel, Kayla, et al.
Publicado: (2023) -
Multiple Indolent Asymptomatic Yellow-Orange Patches and Plaques
por: Niemann, Andrew A, et al.
Publicado: (2022) -
Variants of Erythema Multiforme: A Case Report and Literature Review
por: Paulino, Luis, et al.
Publicado: (2018)